MET and neoplasm: In an attempt to mimic the above clinical condition, we develop a series of biologically relevant genetically engineered mouse models (GEMMs) and demonstrate that aberrant activation of HGF/MET and Wnt signaling pathways in the mouse prostate initiates PCa development, promotes disease progression, and induces DNPC-like tumor lesions.